X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (130) 130
humans (115) 115
helicobacter pylori (102) 102
gastroenterology & hepatology (82) 82
helicobacter infections - drug therapy (67) 67
drug therapy, combination (51) 51
anti-bacterial agents - therapeutic use (50) 50
treatment outcome (48) 48
helicobacter pylori - drug effects (47) 47
antibiotic-resistance (45) 45
infection (45) 45
containing quadruple therapy (44) 44
triple therapy (44) 44
female (40) 40
male (39) 39
sequential therapy (39) 39
microbiology (37) 37
helicobacter infections - microbiology (36) 36
clarithromycin (35) 35
helicobacter infections (34) 34
eradication (33) 33
adult (31) 31
quadruple therapy (31) 31
middle aged (29) 29
amoxicillin (27) 27
antibiotics (26) 26
bifidobacterium-containing yogurt (26) 26
care and treatment (26) 26
probiotics (26) 26
proton pump inhibitors - therapeutic use (25) 25
rescue therapy (25) 25
therapy (24) 24
animals (23) 23
bismuth (23) 23
double-blind (23) 23
drug resistance, bacterial (22) 22
levofloxacin (22) 22
pharmacology & pharmacy (22) 22
resistance (22) 22
eradication therapy (20) 20
helicobacter infections - diagnosis (20) 20
standard triple therapy (20) 20
anti-bacterial agents - administration & dosage (19) 19
anti-bacterial agents - adverse effects (19) 19
proton-pump inhibitor (19) 19
aged (18) 18
concomitant therapy (18) 18
efficacy (18) 18
analysis (17) 17
containing triple therapy (17) 17
health aspects (17) 17
management (17) 17
metronidazole (17) 17
probiotics - therapeutic use (17) 17
amoxicillin - therapeutic use (16) 16
drug administration schedule (16) 16
bismuth - therapeutic use (15) 15
drug resistance in microorganisms (15) 15
helicobacter infections - therapy (15) 15
infections (15) 15
infectious diseases (15) 15
metaanalysis (15) 15
saccharomyces-boulardii (15) 15
antimicrobial resistance (14) 14
bacterial infections and mycoses (14) 14
bismuth-containing quadruple therapy (14) 14
drug resistance (14) 14
drug therapy, combination - methods (14) 14
helicobacter (14) 14
review (14) 14
treatment failure (14) 14
abridged index medicus (13) 13
dosage and administration (13) 13
pylori (13) 13
treatment (13) 13
antibiotic resistance (12) 12
antiulcer drugs (12) 12
clarithromycin - therapeutic use (12) 12
clinical trials (12) 12
drug therapy (12) 12
in-vitro (12) 12
prospective studies (12) 12
proton pump inhibitor (12) 12
proton pump inhibitors - administration & dosage (12) 12
randomized-trial (12) 12
bismuth - administration & dosage (11) 11
breath tests (11) 11
cancer (11) 11
consensus report (11) 11
gastroenterology (11) 11
helicobacter pylori - pathogenicity (11) 11
medicine & public health (11) 11
metronidazole - therapeutic use (11) 11
standard triple (11) 11
studies (11) 11
2nd-line treatment (10) 10
immunology (10) 10
lactobacillus (10) 10
meta-analysis (10) 10
omeprazole (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Helicobacter, ISSN 1083-4389, 06/2017, Volume 22, Issue 3, pp. e12371 - n/a
Journal Article
Journal Article
Medicine (United States), ISSN 0025-7974, 2017, Volume 96, Issue 7, pp. e5859 - e5859
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 01/2013, Volume 68, Issue 1, pp. 222 - 228
Journal Article
Medical Principles and Practice, ISSN 1011-7571, 02/2018, Volume 26, Issue 6, pp. 523 - 529
Journal Article
Helicobacter, ISSN 1083-4389, 12/2012, Volume 17, Issue 6, pp. 458 - 465
Journal Article
Journal Article
Helicobacter, ISSN 1083-4389, 08/2011, Volume 16, Issue 4, pp. 289 - 294
Objectives:  The increasing levels of bacterial antibiotic resistance have increased the need to evaluate the second‐line treatments for Helicobacter pylori .... 
duration | second‐line treatment | quadruple | Helicobacter pylori | eradication | Quadruple | Second-line treatment | Duration | Eradication | STRAINS | second-line treatment | TREATMENT DURATION | MANAGEMENT | EFFICACY | CONTAINING TRIPLE THERAPY | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | KOREA | REGIMENS | FAILURE | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Bismuth - administration & dosage | Prospective Studies | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Urea - analysis | Bismuth - adverse effects | Drug Therapy, Combination - adverse effects | Time Factors | Helicobacter Infections - drug therapy | Metronidazole - adverse effects | Adult | Female | Korea | Anti-Infective Agents - adverse effects | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Metronidazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Treatment Outcome | Tetracycline - adverse effects | Anti-Ulcer Agents - administration & dosage | Drug Therapy, Combination - methods | Medication Adherence | Anti-Infective Agents - administration & dosage | Aged | Helicobacter pylori - isolation & purification | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Tetracycline - administration & dosage | Breath Tests - methods | Drug resistance in microorganisms | Medical colleges | Comparative analysis | Antiulcer drugs | Index Medicus
Journal Article
Gut and Liver, ISSN 1976-2283, 2015, Volume 9, Issue 4, p. 478
Background/Aims: Bismuth-containing quadruple and moxifloxacin-based triple regimens are recommended as second-line therapy for Helicobacter pylori infection.... 
Bismuth-containing quadruple regimen | Helicobacter pylori | Second-line therapy | Moxifloxacin-based triple regimen
Journal Article
Gut and Liver, ISSN 1976-2283, 2015, Volume 9, Issue 4, p. 478
Background/Aims: Bismuth-containing quadruple and moxifloxacin-based triple regimens are recommended as second-line therapy for Helicobacter pylori infection.... 
Bismuth-containing quadruple regimen | Helicobacter pylori | Second-line therapy | Moxifloxacin-based triple regimen
Journal Article
Gut and Liver, ISSN 1976-2283, 2015, Volume 9, Issue 4, p. 478
Background/Aims: Bismuth-containing quadruple and moxifloxacin-based triple regimens are recommended as second-line therapy for Helicobacter pylori infection.... 
Helicobacter pylori | Second-line therapy | Moxifloxacin-based triple regimen | Bis-muth-containing quadruple regimen
Journal Article
Gut and Liver, ISSN 1976-2283, 2015, Volume 9, Issue 4, p. 478
Background/Aims: Bismuth-containing quadruple and moxifloxacin-based triple regimens are recommended as second-line therapy for Helicobacter pylori infection.... 
Bismuth-containing quadruple regimen | Helicobacter pylori | Second-line therapy | Moxifloxacin-based triple regimen
Journal Article